Saved in:
| Main Author: | Krah, Donatus |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.17201752 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Visualizing alpha‐synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo
by: Nadja Straumann, et al.
Published: (2024)
by: Nadja Straumann, et al.
Published: (2024)
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
by: Richard Smith, et al.
Published: (2024)
by: Richard Smith, et al.
Published: (2024)
Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
by: Diana Esteller‐Gauxax, et al.
Published: (2026)
by: Diana Esteller‐Gauxax, et al.
Published: (2026)
Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
by: Jose Miguel Flores‐Fernandez, et al.
Published: (2024)
by: Jose Miguel Flores‐Fernandez, et al.
Published: (2024)
Multi‐scale imaging of α‐synuclein, dopamingeric neurodegeneration and microstructural changes in α‐synuclein PFF mouse model of Parkinson's disease
by: Benjamin F. Combes, et al.
Published: (2025)
by: Benjamin F. Combes, et al.
Published: (2025)
Alzheimer's disease traits in Parkinson's disease without α‐synuclein seeding
by: Bárbara Fernandes Gomes, et al.
Published: (2025)
by: Bárbara Fernandes Gomes, et al.
Published: (2025)
Influence of alpha‐synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α‐synuclein seed amplification assay and FDG‐PET
by: Elijah Mak, et al.
Published: (2025)
by: Elijah Mak, et al.
Published: (2025)
Molecular imaging in Parkinson's disease
by: Polito, Cristina
Published: (2022)
by: Polito, Cristina
Published: (2022)
New items activated in the SLUB catalog in 2023
by: Herre, Donatus
Published: (2024)
by: Herre, Donatus
Published: (2024)
Tear α‐synuclein as a biomarker for Parkinson's disease: A systematic review and meta‐analysis
by: Prince Kwaku Akowuah, et al.
Published: (2024)
by: Prince Kwaku Akowuah, et al.
Published: (2024)
Intra‐striatal infusion of the small molecule alpha‐synuclein aggregator, FN075, does not enhance parkinsonism in a subclinical AAV‐alpha‐synuclein rat model
by: Tommy Patton, et al.
Published: (2024)
by: Tommy Patton, et al.
Published: (2024)
Uso de integración según gauss para calcular la fotosíntesis en modelos de simulación de crecimiento de cultivos
by: Donatus M. Jansen
Published: (1995)
by: Donatus M. Jansen
Published: (1995)
Toward alpha‐synuclein seed amplification assay in clinical practice
by: Mathieu Verdurand, et al.
Published: (2025)
by: Mathieu Verdurand, et al.
Published: (2025)
Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease
by: Dominik Hrabos, et al.
Published: (2024)
by: Dominik Hrabos, et al.
Published: (2024)
Baseline α-synuclein seeding activity and Parkinson's disease progression in the Parkinson's Progression Markers Initiative cohort Key Resource Table
by: Schumacher, Jackson
Published: (2025)
by: Schumacher, Jackson
Published: (2025)
Transformer Outage Contingency in the Southern Interconnected Grid of Cameroon Based on Dynamic Power Flow Simulation
by: Chu Donatus Iweh, et al.
Published: (2024)
by: Chu Donatus Iweh, et al.
Published: (2024)
A Phantom on a Rational Surface
by: Krah, Johannes
Published: (2023)
by: Krah, Johannes
Published: (2023)
The MRI signature of alpha‐synuclein pathology in preclinical stages and in a memory clinic population
by: Laura E.M. Wisse, et al.
Published: (2024)
by: Laura E.M. Wisse, et al.
Published: (2024)
Contribution of alpha‐synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI
by: Samir Abu‐Rumeileh, et al.
Published: (2024)
by: Samir Abu‐Rumeileh, et al.
Published: (2024)
Mutations of Numerically Exceptional Collections on Surfaces
by: Krah, Johannes
Published: (2022)
by: Krah, Johannes
Published: (2022)
Quantitative systems pharmacology model of α‐synuclein pathology in Parkinson's disease‐like mouse for investigation of passive immunotherapy mechanisms
by: Olga Ivanova, et al.
Published: (2024)
by: Olga Ivanova, et al.
Published: (2024)
Glial interaction with Parkinsonian disorders biomarkers: alpha‐synuclein, dopaminergic dysfunction and clinical stages
by: Lara Angi Souza, et al.
Published: (2025)
by: Lara Angi Souza, et al.
Published: (2025)
Physiological, molecular and genetic aspects of alpha-synuclein and its correlation with high alcohol consumption
by: Tania Yadira Martínez-Rodríguez
Published: (2019)
by: Tania Yadira Martínez-Rodríguez
Published: (2019)
The role of polo‐like kinases 2 in the proteasomal and lysosomal degradation of alpha‐synuclein in neurons
by: Chun Chau Sung, et al.
Published: (2024)
by: Chun Chau Sung, et al.
Published: (2024)
The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy
by: Toufik Abdul‐Rahman, et al.
Published: (2024)
by: Toufik Abdul‐Rahman, et al.
Published: (2024)
CSF α‐synuclein reflects neurodegeneration in Alzhiemer's disease
by: Kazuya Igarashi, et al.
Published: (2024)
by: Kazuya Igarashi, et al.
Published: (2024)
Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia
by: Jonna Niskanen, et al.
Published: (2024)
by: Jonna Niskanen, et al.
Published: (2024)
Multi-Agent Reinforcement Learning in Intelligent Transportation Systems: A Comprehensive Survey
by: Donatus, Rexcharles, et al.
Published: (2025)
by: Donatus, Rexcharles, et al.
Published: (2025)
Dementia with Parkinson’s disease. Clinical diagnosis, neuropsychological aspects and treatment
by: Jorge Lorenzo Otero
Published: (2008)
by: Jorge Lorenzo Otero
Published: (2008)
Evaluation of handwriting kinematics and pressure for differential diagnosis of Parkinson's disease
by: Drotár, Peter, et al.
Published: (2024)
by: Drotár, Peter, et al.
Published: (2024)
Seed amplification assay‐determined alpha‐synuclein associates with Alzheimer’s pathology, clinical symptoms, and cognitive change
by: Erin M. Jonaitis, et al.
Published: (2024)
by: Erin M. Jonaitis, et al.
Published: (2024)
Depression preceding and following the diagnosis of Parkinson’s disease and Lewy body dementia
by: Christopher Rohde, et al.
Published: (2025)
by: Christopher Rohde, et al.
Published: (2025)
Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
by: Raimo K. Tuominen, et al.
Published: (2024)
by: Raimo K. Tuominen, et al.
Published: (2024)
Correction to “RTP801 is a critical factor in the neurodegeneration process of A53T a‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress”
Published: (2024)
Published: (2024)
Liquid–liquid phase separation of alpha‐synuclein increases the structural variability of fibrils formed during amyloid aggregation
by: Mantas Ziaunys, et al.
Published: (2024)
by: Mantas Ziaunys, et al.
Published: (2024)
Alpha‐synuclein co‐pathology in Down syndrome‐associated Alzheimer's disease
by: Alexander Maximilian Bernhardt, et al.
Published: (2025)
by: Alexander Maximilian Bernhardt, et al.
Published: (2025)
An interpretable deep learning Bayesian optimized random forest framework for the diagnosis of Parkinson's disease in structural magnetic resonance images
by: Sihem Nour Elhouda Toumi, et al.
Published: (2024)
by: Sihem Nour Elhouda Toumi, et al.
Published: (2024)
How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson's disease diagnosis
by: Cheng Liu, et al.
Published: (2024)
by: Cheng Liu, et al.
Published: (2024)
On proper splinters in positive characteristic
by: Krah, Johannes, et al.
Published: (2023)
by: Krah, Johannes, et al.
Published: (2023)
Autoequivalences of blow‐ups of minimal surfaces
by: Xianyu Hu, et al.
Published: (2024)
by: Xianyu Hu, et al.
Published: (2024)
Similar Items
-
Visualizing alpha‐synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo
by: Nadja Straumann, et al.
Published: (2024) -
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
by: Richard Smith, et al.
Published: (2024) -
Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
by: Diana Esteller‐Gauxax, et al.
Published: (2026) -
Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
by: Jose Miguel Flores‐Fernandez, et al.
Published: (2024) -
Multi‐scale imaging of α‐synuclein, dopamingeric neurodegeneration and microstructural changes in α‐synuclein PFF mouse model of Parkinson's disease
by: Benjamin F. Combes, et al.
Published: (2025)